SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.098
AS - Asia 8.439
EU - Europa 5.690
SA - Sud America 1.383
AF - Africa 138
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.778
SG - Singapore 3.271
CN - Cina 2.667
DE - Germania 1.322
BR - Brasile 1.146
UA - Ucraina 1.000
IT - Italia 974
HK - Hong Kong 839
TR - Turchia 724
GB - Regno Unito 572
VN - Vietnam 426
SE - Svezia 366
FI - Finlandia 364
RU - Federazione Russa 335
PL - Polonia 241
FR - Francia 185
CA - Canada 162
MX - Messico 131
AR - Argentina 97
ID - Indonesia 91
IN - India 91
NL - Olanda 86
BD - Bangladesh 71
JP - Giappone 71
ZA - Sudafrica 67
ES - Italia 55
BE - Belgio 47
IQ - Iraq 43
LT - Lituania 43
EC - Ecuador 39
CO - Colombia 22
CL - Cile 20
CZ - Repubblica Ceca 20
VE - Venezuela 20
MA - Marocco 19
AE - Emirati Arabi Uniti 18
AT - Austria 18
PY - Paraguay 17
PK - Pakistan 15
KR - Corea 14
IL - Israele 12
UZ - Uzbekistan 12
DZ - Algeria 11
KE - Kenya 11
AU - Australia 10
SA - Arabia Saudita 10
EG - Egitto 9
PE - Perù 9
JO - Giordania 8
NP - Nepal 8
IR - Iran 7
TN - Tunisia 7
BO - Bolivia 6
EU - Europa 6
IE - Irlanda 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
HN - Honduras 5
MY - Malesia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
GT - Guatemala 4
KZ - Kazakistan 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IM - Isola di Man 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
Totale 32.750
Salva come PNG Salva come JPEG
Città #
Singapore 1.887
Woodbridge 1.755
Ashburn 1.580
Fairfield 1.554
Jacksonville 1.093
Chandler 1.077
Houston 1.050
Ann Arbor 878
Beijing 870
Hong Kong 833
Santa Clara 815
Seattle 659
Wilmington 641
Cambridge 532
Dallas 396
Izmir 365
Nanjing 335
Los Angeles 313
Ferrara 300
Princeton 255
Warsaw 223
Munich 219
Milan 209
Boardman 199
New York 169
Ho Chi Minh City 155
Shanghai 144
Dearborn 126
São Paulo 120
San Diego 115
Shenyang 111
Nanchang 105
Addison 90
Hefei 89
Hanoi 86
Tianjin 86
Falkenstein 85
London 83
Bremen 82
Turku 80
Mexico City 76
Helsinki 73
Jakarta 71
Buffalo 69
Changsha 64
Hebei 64
Frankfurt am Main 63
Tokyo 61
Montreal 60
Chicago 53
Brooklyn 51
Jinan 47
Jiaxing 46
Bologna 45
Brussels 45
San Mateo 43
Toronto 42
San Francisco 41
Falls Church 39
Moscow 39
Boston 36
Johannesburg 36
Kunming 36
Orem 36
Mountain View 35
Poplar 35
Zhengzhou 34
Norwalk 33
Phoenix 33
Rio de Janeiro 33
Stockholm 33
Denver 31
The Dalles 31
Atlanta 30
Chennai 29
Manchester 29
Council Bluffs 27
Guangzhou 27
Auburn Hills 26
Ningbo 26
Haiphong 25
Philadelphia 25
Redwood City 25
Brasília 24
Mumbai 24
Columbus 23
Belo Horizonte 22
Amsterdam 21
Des Moines 20
Ankara 19
Orange 19
Rome 19
Verona 19
Dhaka 18
Nuremberg 18
Biên Hòa 17
Porto Alegre 17
Charlotte 16
Hangzhou 16
Lanzhou 16
Totale 21.895
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 295
A glance at adenosine receptors: Novel target for antitumor therapy 261
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 252
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 227
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 217
The A3 adenosine receptor: history and perspectives 216
Adenosine receptors and human melanoma 215
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 213
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 210
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 200
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 200
Adenosine receptor targeting in health and disease 199
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 196
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 196
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 195
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 193
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 191
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 190
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Adenosine receptors and cancer 183
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 183
van't Hoff Based Thermodynamics 182
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 180
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 178
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 178
Pathological overproduction: the bad side of adenosine 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 176
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 175
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 174
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 172
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 171
Adenosine receptors in health and disease 171
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 171
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 170
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 170
Agonists and antagonists: Molecular mechanisms and therapeutic applications 170
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 169
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 168
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 168
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 167
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 166
A(2A) adenosine receptors in human peripheral blood cells 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 164
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 164
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 163
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 162
Adenosine and lymphocyte regulation 162
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 161
New potent and selective human adenosine A3 receptor antagonists. 161
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 158
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 158
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 157
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 157
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 157
The A3 adenosine receptor: An enigmatic player in cell biology 156
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 156
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 156
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
Targeting A3 and A2A adenosine receptors in the fight against cancer 154
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 153
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 153
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 153
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 151
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 151
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 150
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 150
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 149
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 148
New potent and selective human adenosine A3 receptor antagonists 148
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 146
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 145
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 145
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 145
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 144
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 144
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 144
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 142
Adenosine A2A receptors in human circulating blood elements 142
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 142
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 141
Adenosine in a human model of Hypoxic foam cells 141
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 141
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 140
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 139
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 139
Totale 17.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.066
Totale 156.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.830 0 0 0 0 0 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/20268.043 1.635 571 1.351 1.978 2.329 179 0 0 0 0 0 0
Totale 33.098